COMPASS Pathways plc (NASDAQ:CMPS) Receives Average Rating of "Buy" from Analysts

Shares of COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) have earned an average recommendation of "Buy" from the six brokerages that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $20.20.

CMPS has been the subject of a number of research analyst reports. Cantor Fitzgerald upgraded COMPASS Pathways to a "strong-buy" rating in a report on Tuesday, May 13th. HC Wainwright reiterated a "buy" rating and set a $45.00 price target on shares of COMPASS Pathways in a report on Monday, May 12th. Stifel Nicolaus initiated coverage on COMPASS Pathways in a report on Thursday, February 27th. They set a "buy" rating and a $11.00 price target for the company. Finally, Canaccord Genuity Group cut their price target on COMPASS Pathways from $23.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 28th.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Acadian Asset Management LLC boosted its stake in COMPASS Pathways by 42.0% during the first quarter. Acadian Asset Management LLC now owns 240,591 shares of the company's stock worth $686,000 after buying an additional 71,112 shares in the last quarter. Woodline Partners LP raised its stake in shares of COMPASS Pathways by 279.9% in the 1st quarter. Woodline Partners LP now owns 1,754,856 shares of the company's stock valued at $5,019,000 after buying an additional 1,292,927 shares in the last quarter. Polar Asset Management Partners Inc. acquired a new position in shares of COMPASS Pathways in the 1st quarter valued at $657,000. Nantahala Capital Management LLC raised its stake in shares of COMPASS Pathways by 182.9% in the 1st quarter. Nantahala Capital Management LLC now owns 2,829,232 shares of the company's stock valued at $8,092,000 after buying an additional 1,829,232 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in shares of COMPASS Pathways by 49.8% in the 1st quarter. Royal Bank of Canada now owns 89,446 shares of the company's stock valued at $256,000 after buying an additional 29,733 shares in the last quarter. 46.19% of the stock is currently owned by institutional investors and hedge funds.

COMPASS Pathways Stock Performance

CMPS traded up $0.18 on Monday, hitting $4.36. The company had a trading volume of 982,547 shares, compared to its average volume of 836,152. The company's fifty day moving average price is $3.44 and its 200 day moving average price is $3.93. COMPASS Pathways has a 1-year low of $2.49 and a 1-year high of $8.54. The company has a debt-to-equity ratio of 0.15, a current ratio of 8.91 and a quick ratio of 8.91. The stock has a market cap of $404.82 million, a price-to-earnings ratio of -1.98 and a beta of 2.27.

COMPASS Pathways (NASDAQ:CMPS - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.03. Equities analysts predict that COMPASS Pathways will post -2.33 earnings per share for the current fiscal year.

About COMPASS Pathways

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.